Loncar China BioPharma ETF – NASDAQ:CHNA

Add to watchlist

Market closed

Open in about 5 hours

-2.44%

month

-15.06%

quarter

-5.01%

year

Market Cap	N/A
Enterprise value	N/A

P/E	N/A
EV/Sales	N/A
EV/EBITDA	N/A
Price/Sales	N/A
Price/Book	N/A
PEG ratio	N/A
EPS	N/A

Revenue	N/A
EBITDA	N/A
Income	N/A
Revenue Q/Q	N/A
Revenue Y/Y	N/A

Profit margin	0%
Oper. margin	0%
Gross margin	0%
EBIT margin	0%
EBITDA margin	N/A

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Loncar China BioPharma ETF
Latest News

Wednesday, 22 May 2024
07:00	CI Global Asset Management Announces Risk Rating Change for CI ICBCCS S&P China 500 Index ETF	businesswire.com
Wednesday, 21 February 2024
02:09	Enter The Dragon: Parsing Lunar New Year Opportunities Among Emerging Markets	Seeking Alpha
Wednesday, 7 February 2024
17:07	Why China May Need To Do More To Boost Investor Confidence	Seeking Alpha
07:08	China Begins Year Of The Dragon With Weak Economic Momentum	Seeking Alpha
Wednesday, 24 January 2024
22:15	Restarting China's Economic Growth	Seeking Alpha
Tuesday, 23 January 2024
15:15	China Canary Warns About Global Economy And The Downside To Euphoria	Seeking Alpha
Tuesday, 31 October 2023
13:59	China: Momentum Waned In October	Seeking Alpha
Friday, 27 October 2023
15:13	This Week in ETFs: 4 New Single-Stock Funds Debut	ETF Trends
Monday, 9 October 2023
19:50	China Could Derail Japan's Fragile Recovery	Seeking Alpha
Tuesday, 20 June 2023
20:44	Will China's Efforts To Boost Its Struggling Economy Pay Off?	Seeking Alpha
Monday, 23 January 2023
14:18	What Lies Ahead for China ETFs in the Year of Rabbit?	Zacks Investment Research
Tuesday, 10 January 2023
09:05	China: Timing Of Recovery Is A Big Question Mark	Seeking Alpha
Monday, 9 January 2023
20:10	China ETFs Lead the Way in This Week's Top Performing ETFs	ETF Trends
Tuesday, 3 January 2023
15:47	Top-Performing ETF Areas of Last Week	Zacks Investment Research
Thursday, 29 December 2022
14:17	4 Best Areas of Q4 Up At Least 20% & Their Top ETFs	Zacks Investment Research
Monday, 21 November 2022
15:48	5 Best-Performing ETFs of Last Week	Zacks Investment Research
Wednesday, 16 November 2022
09:02	China ETFs Rallying: Top Gainers Past Month	Zacks Investment Research
Wednesday, 2 November 2022
14:46	China After The National Party Congress: 3 Challenges Facing The Country	Seeking Alpha
Saturday, 29 October 2022
08:24	China Still Investible--If You Know Where To Look	Seeking Alpha
Tuesday, 4 October 2022
09:30	What To Expect From China's 20th Party Congress	Seeking Alpha
Thursday, 1 September 2022
11:46	Asian Exports Are Softening	Seeking Alpha
Monday, 29 August 2022
10:00	The Challenges Ahead For China's Economy	Seeking Alpha
Thursday, 4 August 2022
16:32	China's Economy Has Faced Headwinds, But Are Investment Opportunities Emerging?	Seeking Alpha
Friday, 1 July 2022
11:05	China's Stimulative Policy Actions: Turning The Tide For Investors	Seeking Alpha
Wednesday, 29 June 2022
11:13	China's Economic Outlook For The Second Half Of 2022	Seeking Alpha
Wednesday, 1 June 2022
13:45	China Growth: Brighter Prospects?	Seeking Alpha
Saturday, 7 May 2022
13:45	The Chinese Slowdown: Much More Than Covid	Seeking Alpha
Thursday, 18 November 2021
12:20	Mind The Bond Market	Seeking Alpha
Friday, 5 November 2021
08:11	China's Next Phase Can Make You Money Or Steal Your Savings	Seeking Alpha
Sunday, 26 September 2021
12:09	Evergrande Isn't China's 'Lehman Moment.' It Could Be Worse Than That	Seeking Alpha

Ideas & Opinions

Seeking Alpha 23 Aug 2022

Circling Back On Precigen

Frequently Asked Questions (FAQ)

When is Loncar China BioPharma ETF's next earnings date?

Unfortunately, Loncar China BioPharma ETF's (CHNA) next earnings date is currently unknown.
Does Loncar China BioPharma ETF pay dividends?

Yes, Loncar China BioPharma ETF pays dividends and its trailing 12-month yield is 0.5% with 0% payout ratio. The last Loncar China BioPharma ETF stock dividend of $0.16 was paid on 4 Jan 2021.
What is Loncar China BioPharma ETF's stock symbol?

Loncar China BioPharma ETF is traded on the NASDAQ under the ticker symbol "CHNA".
What is Loncar China BioPharma ETF's primary industry?

Company operates in the Financial Services sector and Asset Management industry.
How do i buy shares of Loncar China BioPharma ETF?

Shares of Loncar China BioPharma ETF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
When Loncar China BioPharma ETF went public?

Loncar China BioPharma ETF is publicly traded company for more then 7 years since IPO on 15 Aug 2018.

Loncar China BioPharma ETF

Exchange:

NASDAQ

Full time employees:

Industry:

Asset Management

Sector:

Financial Services

The Advisor attempts to invest all, or substantially all, of its assets in the component securities and depositary receipts that make up the index. The index seeks to track the performance of a modified equal-weighted portfolio of companies directly involved in the growth of China's pharmaceutical and biotech related industries.

CIK: 0001540305
ISIN: US26922A3703
: